Tearsheet

Owens & Minor (OMI)

Market Price (9/15/2025): $5.24 | Market Cap: $403.1 Mil
Sector: Health Care | Industry: Health Care Distributors

Owens & Minor (OMI)

Market Price (9/15/2025): $5.24
Market Cap: $403.1 Mil
Sector: Health Care
Industry: Health Care Distributors

Investment Highlights

0	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -31%	Weak multi-year price returns 2Y Excs Rtn is -116%, 3Y Excs Rtn is -146%	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 492%
1		Meaningful short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 12%	Weak revenue growth Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.6%
2			Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.9%
3			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -297%

0	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -31%
1	Weak multi-year price returns 2Y Excs Rtn is -116%, 3Y Excs Rtn is -146%
2	Meaningful short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 12%
3	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 492%
4	Weak revenue growth Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.6%
5	Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.9%
6	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -297%

Market Valuation

	9/15/25	2024	2023	2022	2021
Share Price CYE	$5.24	$13.07	$19.27	$19.53	$43.50
Market Cap CYE ($ Mil)	403.1	1,006.3	1,465.8	1,461.9	3,176.8
Total Debt ($ Mil)	2,058.7	2,139.8	2,319.9	2,716.3	1,109.8
Total Cash ($ Mil)	38.3	49.4	243.0	69.5	55.7
Enterprise Value ($ Mil)	2,423.6	3,146.1	3,785.7	4,178.2	4,286.6
Valuation Ratios
P/S TTM	0.1	0.1	0.1	0.1	0.3
P/EBIT TTM	-1.3	-4.7	14.2	10.4	9.7
P/E TTM	-0.3	-2.8	-35.4	65.0	14.3
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1	4.5	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3	-2.9
P/E TTM (Sector)	-1.9	-1.6	-1.5	-1.4	-2.9

	9/15/25	2024	2023
Share Price CYE	$5.24	$13.07	$19.27
Market Cap CYE ($ Mil)	403.1	1,006.3	1,465.8
Total Debt ($ Mil)	2,058.7	2,139.8	2,319.9
Total Cash ($ Mil)	38.3	49.4	243.0
Enterprise Value ($ Mil)	2,423.6	3,146.1	3,785.7
Valuation Ratios
P/S TTM	0.1	0.1	0.1
P/EBIT TTM	-1.3	-4.7	14.2
P/E TTM	-0.3	-2.8	-35.4
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4
P/E TTM (Sector)	-1.9	-1.6	-1.5

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
OMI Return	424%	61%	-55%	-1%	-32%	-59%	3%
Peers Return	96%	32%	16%	15%	2%	6%	276%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: MCK, CAH, HSIC, COR, OMI. See OMI Returns vs. Peers.
[3] 2025 data is for the year up to 9/12/2025 (YTD)

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Day 5 of Loss Streak for Owens & Minor Stock with -11% Return (vs. -61% YTD) [8/22/2025]	Notification
2	Owens & Minor (OMI) Operating Cash Flow Comparison	Financials
3	Owens & Minor (OMI) Operating Income Comparison	Financials
4	Owens & Minor (OMI) Net Income Comparison	Financials
5	Owens & Minor (OMI) Debt Comparison	Financials
6	Owens & Minor (OMI) EBITDA Comparison	Financials
7	Owens & Minor (OMI) Tax Expense Comparison	Financials
8	Owens & Minor (OMI) Revenue Comparison	Financials
9	OMI Dip Buy Analysis
10	Owens & Minor Total Shareholder Return (TSR): -32.2% in 2024 and -33.0% 3-yr compounded annual returns (below peer average)
11	ARTICLES
12	OMI Stock Down -11% after 5-Day Loss Streak		August 22nd, 2025
13	Market Movers \| Winners: TLRY, TGNA, MLNK \| Losers: OMI, AI, MAX		August 12th, 2025
14	OMI Stock Up 29% after 6-Day Win Streak		July 2nd, 2025
15	Is There A Better Pick Over Owens & Minor Stock?		March 18th, 2022
16	Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?		November 9th, 2021

	Title
0	DASHBOARDS
1	OMI Stock Down -11% after 5-Day Loss Streak
2	Market Movers \| Winners: TLRY, TGNA, MLNK \| Losers: OMI, AI, MAX
3	OMI Stock Up 29% after 6-Day Win Streak
4	Is There A Better Pick Over Owens & Minor Stock?
5	Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?
6	ARTICLES
7	Day 5 of Loss Streak for Owens & Minor Stock with -11% Return (vs. -61% YTD) [8/22/2025]
8	Owens & Minor (OMI) Operating Cash Flow Comparison
9	Owens & Minor (OMI) Operating Income Comparison
10	Owens & Minor (OMI) Net Income Comparison
11	Owens & Minor (OMI) Debt Comparison
12	Owens & Minor (OMI) EBITDA Comparison
13	Owens & Minor (OMI) Tax Expense Comparison
14	Owens & Minor (OMI) Revenue Comparison
15	OMI Dip Buy Analysis
16	Owens & Minor Total Shareholder Return (TSR): -32.2% in 2024 and -33.0% 3-yr compounded annual returns (below peer average)

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GCTK	GlucoTrack	117.5%	-97.6%
2	OPI	Office Properties Income Trust	78.6%	-42.6%
3	HCWB	HCW Biologics	68.4%	-68.7%
4	AGAE	Allied Gaming & Entertainment	62.4%	86.8%
5	ATCH	AtlasClear	53.4%	-95.9%
6	SONN	Sonnet BioTherapeutics	49.0%	304.1%
7	EVTV	Envirotech Vehicles	48.4%	-66.3%
8	ISPC	iSpecimen	47.7%	-26.6%
9	ENTO	Entero Therapeutics	37.0%	68.8%
10	IBEX	IBEX	36.5%	93.5%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	-57.4%	-93.8%
2	VCIG	VCI Global	-42.8%	-98.7%
3	RENT	Rent the Runway	-36.4%	-40.9%
4	NUAI	New Era Energy & Digital	-30.5%
5	AEI	Alset	-29.6%	156.9%
6	NAKA	Kindly MD	-29.5%
7	XTIA	XTI Aerospace	-24.6%	-85.8%
8	FARM	Farmer Bros	-21.5%	1.7%
9	FEIM	Frequency Electronics	-21.0%	46.5%
10	MSS	Maison Solutions	-20.4%	-27.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	OCTO	Eightco	900.0%	562.1%
2	QMMM	QMMM	875.3%	5698.4%
3	WLDS	Wearable Devices	780.4%	8.0%
4	CWD	CaliberCos	268.8%	-45.1%
5	AIRE	ReAlpha Tech	257.5%	-49.8%
6	PTNM	Pitanium	154.0%
7	OPI	Office Properties Income Trust	144.0%	-42.6%
8	HYPD	Hyperion DeFi	144.0%
9	ISPC	iSpecimen	128.4%	-26.6%
10	EDHL	Everbright Digital	127.6%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-85.6%
2	LGCL	Lucas GC	-69.1%	-76.6%
3	YYGH	YY	-68.7%	-76.6%
4	BINI	Bollinger Innovations	-61.6%	-100.0%
5	IPDN	Professional Diversity Network	-54.5%	-41.4%
6	INHD	Inno	-53.4%	-4.4%
7	CDT	CDT Equity	-49.2%	-99.4%
8	NFE	New Fortress Energy	-46.5%	-91.3%
9	TGHL	Growhub	-44.8%
10	SLXN	Silexion Therapeutics	-43.1%	-86.5%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	11249.2%	11249.2%
2	GIBO	GIBO	7400.0%
3	LNZA	LanzaTech Global	4710.5%	-85.8%
4	CHSN	Chanson International	3717.0%	-99.3%
5	QMMM	QMMM	2669.4%	5698.4%
6	VTAK	Catheter Precision	1332.7%	-71.4%
7	CURX	Curanex Pharmaceuticals	1309.0%	1309.0%
8	OCTO	Eightco	811.9%	562.1%
9	WLDS	Wearable Devices	708.6%	8.0%
10	PTNM	Pitanium	423.7%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	BINI	Bollinger Innovations	-93.4%	-100.0%
2	ETS	Elite Express	-92.8%	-92.8%
3	CJET	Chijet Motor	-92.7%	-94.6%
4	ELPW	Elong Power	-91.7%	-75.8%
5	STFS	Star Fashion Culture	-91.4%	-97.8%
6	JEM	707 Cayman	-90.4%	-98.0%
7	FLYE	Fly-E	-90.4%	-82.8%
8	NXTT	Next Technology	-89.3%	-93.8%
9	NUTR	NusaTrip	-87.2%	-87.2%
10	CUPR	Cuprina	-84.3%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GCTK	GlucoTrack	117.5%	-97.6%
2	OPI	Office Properties Income Trust	78.6%	-42.6%
3	HCWB	HCW Biologics	68.4%	-68.7%
4	AGAE	Allied Gaming & Entertainment	62.4%	86.8%
5	ATCH	AtlasClear	53.4%	-95.9%
6	SONN	Sonnet BioTherapeutics	49.0%	304.1%
7	EVTV	Envirotech Vehicles	48.4%	-66.3%
8	ISPC	iSpecimen	47.7%	-26.6%
9	ENTO	Entero Therapeutics	37.0%	68.8%
10	IBEX	IBEX	36.5%	93.5%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	-57.4%	-93.8%
2	VCIG	VCI Global	-42.8%	-98.7%
3	RENT	Rent the Runway	-36.4%	-40.9%
4	NUAI	New Era Energy & Digital	-30.5%
5	AEI	Alset	-29.6%	156.9%
6	NAKA	Kindly MD	-29.5%
7	XTIA	XTI Aerospace	-24.6%	-85.8%
8	FARM	Farmer Bros	-21.5%	1.7%
9	FEIM	Frequency Electronics	-21.0%	46.5%
10	MSS	Maison Solutions	-20.4%	-27.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	OCTO	Eightco	900.0%	562.1%
2	QMMM	QMMM	875.3%	5698.4%
3	WLDS	Wearable Devices	780.4%	8.0%
4	CWD	CaliberCos	268.8%	-45.1%
5	AIRE	ReAlpha Tech	257.5%	-49.8%
6	PTNM	Pitanium	154.0%
7	OPI	Office Properties Income Trust	144.0%	-42.6%
8	HYPD	Hyperion DeFi	144.0%
9	ISPC	iSpecimen	128.4%	-26.6%
10	EDHL	Everbright Digital	127.6%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-85.6%
2	LGCL	Lucas GC	-69.1%	-76.6%
3	YYGH	YY	-68.7%	-76.6%
4	BINI	Bollinger Innovations	-61.6%	-100.0%
5	IPDN	Professional Diversity Network	-54.5%	-41.4%
6	INHD	Inno	-53.4%	-4.4%
7	CDT	CDT Equity	-49.2%	-99.4%
8	NFE	New Fortress Energy	-46.5%	-91.3%
9	TGHL	Growhub	-44.8%
10	SLXN	Silexion Therapeutics	-43.1%	-86.5%

Peer Comparisons for Owens & Minor

Financials

	OMI	MCK	CAH	HSIC	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Cencora
Mkt Price	5.34	711.42	152.24	69.01	302.52	152.24
Mkt Cap	0.4	88.9	36.2	8.4	58.6	36.2
Rev LTM	8,731	377,595	222,578	12,773	316,654	222,578
Op Inc LTM	287	4,748	2,322	771	3,713	2,322
FCF LTM	-166	5,666	1,850	334	1,142	1,142
FCF 3Y Avg	130	4,463	2,488	436	2,588	2,488
CFO LTM	101	6,547	2,397	512	1,742	1,742
CFO 3Y Avg	353	5,194	3,001	619	3,101	3,001

Growth & Margins

	OMI	MCK	CAH	HSIC	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Cencora
Rev Chg LTM	2.5%	20.3%	-1.9%	2.3%	11.6%	2.5%
Rev Chg 3Y Avg	-3.6%	12.2%	7.3%	0.2%	10.3%	7.3%
Rev Chg Q	3.3%	23.4%	0.5%	3.3%	8.7%	3.3%
QoQ Delta Rev Chg LTM	0.2%	5.2%	0.1%	0.8%	2.1%	0.8%
Op Mgn LTM	3.3%	1.3%	1.0%	6.0%	1.2%	1.3%
Op Mgn 3Y Avg	2.8%	1.4%	1.0%	5.8%	1.1%	1.4%
QoQ Delta Op Mgn LTM	0.1%	-0.1%	0.0%	-0.0%	0.0%	0.0%
CFO/Rev LTM	1.2%	1.7%	1.1%	4.0%	0.6%	1.2%
CFO/Rev 3Y Avg	3.7%	1.6%	1.4%	4.9%	1.1%	1.6%
FCF/Rev LTM	-1.9%	1.5%	0.8%	2.6%	0.4%	0.8%
FCF/Rev 3Y Avg	1.3%	1.4%	1.1%	3.5%	0.9%	1.3%

Valuation

	OMI	MCK	CAH	HSIC	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Cencora
Mkt Cap	0.4	88.9	36.2	8.4	58.6	36.2
P/S	0.0	0.2	0.2	0.7	0.2	0.2
P/EBIT	-1.4	19.5	15.6	12.7	20.0	15.6
P/E	-0.3	28.1	23.2	21.6	30.9	23.2
P/CFO	4.1	13.6	15.1	16.4	33.7	15.1
Total Yield	-292.8%	4.0%	5.7%	4.6%	4.0%	4.0%
Dividend Yield	0.0%	0.4%	1.4%	0.0%	0.7%	0.4%
FCF Yield 3Y Avg	6.1%	6.1%	9.3%	4.8%	5.9%	6.1%
D/E	5.0	0.1	0.2	0.4	0.1	0.2
Net D/E	4.9	0.1	0.1	0.4	0.1	0.1

Returns

	OMI	MCK	CAH	HSIC	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Cencora
1M Rtn	-6.0%	5.8%	1.8%	1.7%	3.3%	1.8%
3M Rtn	-31.5%	-2.2%	-5.4%	-1.7%	2.6%	-2.2%
6M Rtn	-43.1%	9.6%	19.7%	-2.2%	17.7%	9.6%
12M Rtn	-65.6%	37.7%	36.6%	-1.9%	27.2%	27.2%
3Y Rtn	-78.6%	111.5%	143.9%	-4.1%	123.5%	111.5%
1M Excs Rtn	-1.6%	5.6%	1.0%	-1.8%	2.3%	1.0%
3M Excs Rtn	-41.9%	-11.5%	-13.8%	-11.8%	-6.2%	-11.8%
6M Excs Rtn	-61.5%	-8.5%	2.1%	-20.4%	-0.6%	-8.5%
12M Excs Rtn	-82.8%	21.5%	15.4%	-17.7%	8.6%	8.6%
3Y Excs Rtn	-146.1%	31.1%	62.7%	-70.0%	45.9%	31.1%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End		12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date		2/28/2025	2/20/2024	2/28/2023	2/23/2022	2/24/2021	3/4/2020
Key Financials
Total Revenue	8,731	10,701	10,334	9,955	9,785	8,480	9,211
Ebitda	-54	51	391	368	415	287	186
Operating Income	287	296	305	277	442	242	103
Net Income	-1,203	-363	-41	22	222	30	-62
EPS	-15.63	-4.73	-0.54	0.30	3.05	0.47	-1.03
Growth Rates
Total Revenue Growth	2.5%	3.6%	3.8%	1.7%	15.4%	-7.9%	-2.2%
EBITDA Growth	-113.7%	-86.9%	6.0%	-11.3%	44.9%	54.0%	173.2%
Operating Income Growth	-3.9%	-2.8%	10.1%	-37.4%	82.9%	134.4%	-14.5%
Net Income Growth	-2734.3%	-778.2%	-284.5%	-89.9%	641.8%	147.9%	85.7%
Margins
EBITDA Margin	-0.6%	0.5%	3.8%	3.7%	4.2%	3.4%	2.0%
Operating Income Margin	3.3%	2.8%	2.9%	2.8%	4.5%	2.9%	1.1%
Net Income Margin	-13.8%	-3.4%	-0.4%	0.2%	2.3%	0.4%	-0.7%
Cash & Debt
Total Cash	38	49	243	69	56	83	67
Total Debt	2,059	2,140	2,320	2,716	1,110	1,106	1,625
Net Debt / (Cash)	2,020	2,090	2,077	2,647	1,054	1,023	1,558
Cash Flows
Net Cash from Operations	101	161	741	325	124	339	166
Free Cash from Operations	-166	-67	533	158	74	280	114
Returns to Shareholders
Dividends	0	-0	-0	-0	1	1	5
Share Repurchases	7	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/11/2025	5/8/2025	2/28/2025	11/4/2024	8/2/2024	5/3/2024	2/20/2024	11/3/2023	8/4/2023	5/5/2023	2/28/2023	11/2/2022
Key Financials Quarterly
Total Revenue	682	2,632	2,696	2,721	660	2,613	2,656	2,592	2,563	2,523	2,551	2,497
Ebitda	0	60	-199	84	80	83	129	101	82	79	19	118
Operating Income	57	61	95	74	46	57	111	84	62	48	-25	83
Net Income	-869	-25	-296	-13	-32	-22	18	-6	-28	-24	-58	12
EPS	-11.30	-0.32	-3.84	-0.17	-0.42	-0.29	0.23	-0.08	-0.37	-0.32	-0.77	0.17
Key Financials TTM
Total Revenue TTM	8,731	8,710	8,690	8,650	8,521	10,424	10,334	10,229	10,135	10,071	9,955	9,872
Ebitda TTM	-54	26	48	376	392	394	391	281	298	363	368	433
Operating Income TTM	287	276	273	288	298	314	305	169	168	220	277	417
Net Income TTM	-1,203	-366	-363	-49	-42	-39	-41	-117	-98	-41	22	122
Growth Rates Quarterly
Total Revenue Growth	3.3%	0.7%	1.5%	5.0%	-74.2%	3.6%	4.1%	3.8%	2.5%	4.8%	3.4%	-0.2%
EBITDA Growth	-99.4%	-27.3%	-254.6%	-16.3%	-2.3%	4.1%	578.0%	-14.3%	-44.5%	-6.0%	-77.3%	38.8%
Operating Income Growth	23.1%	6.4%	-14.3%	-11.9%	-25.6%	20.3%	541.0%	0.9%	-45.4%	-54.5%	-121.9%	20.5%
Net Income Growth	-2623.2%	-14.1%	-1765.1%	-98.7%	-13.0%	10.4%	130.7%	-151.4%	-198.7%	-162.2%	-238.2%	-71.7%
Margins Quarterly
EBITDA Margin	0.1%	2.3%	-7.4%	3.1%	12.1%	3.2%	4.8%	3.9%	3.2%	3.1%	0.7%	4.7%
Operating Income Margin	8.3%	2.3%	3.5%	2.7%	7.0%	2.2%	4.2%	3.3%	2.4%	1.9%	-1.0%	3.3%
Net Income Margin	-127.4%	-0.9%	-11.0%	-0.5%	-4.8%	-0.8%	0.7%	-0.2%	-1.1%	-1.0%	-2.3%	0.5%
Cash & Debt
Total Cash	38	59	49	45	244	245	243	215	286	67	69	77
Total Debt	2,059	2,271	2,140	2,173	2,380	2,430	2,320	2,339	2,525	2,571	2,716	2,762
Net Debt / (Cash)	2,020	2,212	2,090	2,128	2,137	2,185	2,077	2,124	2,238	2,504	2,647	2,685
Cash Flows Quarterly
FCF from Operations	38	-35	71	27	116	-53	112	157	313	158	87	69
Cash Flows TTM
FCF from Operations TTM	101	179	161	202	332	529	741	716	627	404	325	288
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	5	2	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	8.6%	6.2%	14.2%	10.2%	4.9%	6.8%	14.3%	7.4%	8.1%	4.5%	-1.9%	6.7%
Return on Invested Capital (ROIC) TTM
ROIC TTM	10.6%	9.4%	9.9%	8.6%	7.2%	9.3%	8.7%	4.3%	4.2%	4.2%	8.7%	10.3%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Products & Healthcare Services	7,781	7,898	8,826
Patient Direct	2,553	2,057	960
Global Products				1,810	1,434
Global Solutions				7,212	8,244
Inter-segment net revenue				-542	-467
Total	10,334	9,955	9,785	8,480	9,211

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
Patient Direct	247	194	58
Products & Healthcare Services	58	175	384
Exit and realignment charges, net	-99	-7	-31
Acquisition-related charges and intangible amortization	-101	-127	-43
Inventory valuation adjustment		-92	0
Acquisition-related and exit and realignment charges				-38	-30
Global Products				260	65
Global Solutions				31	84
Intangible amortization				-41	-44
Inter-segment eliminations				-8	0
Other					-1
Total	105	143	368	204	73

Assets by Segment

$ Mil	2024	2021	2020
Patient Direct	2,490
Products & Healthcare Services	2,360
Cash and cash equivalents	243	83	67
Global Products		1,135	931
Global Solutions		2,117	2,205
Discontinued operations			440
Total	5,093	3,336	3,643

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$5.34
Market Cap ($ Bil)	0.4
First Trading Date	12/16/1988
Distance from 52W High	-67.0%
	50 Days	200 Days
DMA Price	$6.54	$8.94
DMA Trend	down	down
Distance from DMA	-18.4%	-40.3%
	3M	1YR
Volatility	100.6%	89.3%
Downside Capture	779.37	257.52
Upside Capture	183.69	108.47
Correlation (SPY)	30.3%	22.2%

OMI Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	4.87	4.42	3.69	0.71	1.01	1.37
Up Beta	4.88	5.55	4.51	0.02	0.46	1.26
Down Beta	-1.79	0.38	0.70	0.62	0.66	0.90
Up Capture	424%	117%	274%	94%	115%	187%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	7	12	24	55	110	365
Down Capture	950%	842%	555%	176%	155%	109%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	14	29	38	70	136	378

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	8292025
Short Interest: Shares Quantity	9,197,175
Short Interest: % Change Since 8152025	24.4%
Average Daily Volume	1,537,413
Days-to-Cover Short Interest	5.98
Basic Shares Quantity	76,935,000
Short % of Basic Shares	12.0%

Returns Analyses

	Title
0	Will You Be Comfortable Buying Owens & Minor Stock?
1	Owens & Minor Stock Return Comparison
2	[10/15/2021] Owens & Minor (OMI) Stock Price Forecast: AI Forecasts OMI Stock Price To Be Around $33.80 In A Month (Up 2.5%)
3	Owens & Minor (OMI) Stock Return: AI Predicts OMI Average and Excess Return After a Fall or Rise

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
8/11/2025	-34.7%	-19.9%	-22.0%
5/8/2025	-9.9%	-9.8%	3.2%
2/3/2025	-35.2%	-39.3%	-31.8%
11/4/2024	-10.2%	-3.4%	7.3%
7/23/2024	7.6%	0.8%	2.1%
5/3/2024	-25.7%	-25.0%	-28.5%
2/20/2024	1.6%	11.6%	19.1%
11/3/2023	27.1%	13.7%	46.3%
...
SUMMARY STATS
# Positive	8	8	12
# Negative	13	13	9
Median Positive	7.2%	12.7%	13.7%
Median Negative	-11.5%	-17.4%	-20.5%
Max Positive	29.2%	29.8%	46.3%
Max Negative	-35.2%	-39.3%	-33.7%

	Forward Returns
8/11/2025	-34.7%	-19.9%	-22.0%
5/8/2025	-9.9%	-9.8%	3.2%
2/3/2025	-35.2%	-39.3%	-31.8%
11/4/2024	-10.2%	-3.4%	7.3%
7/23/2024	7.6%	0.8%	2.1%
5/3/2024	-25.7%	-25.0%	-28.5%
2/20/2024	1.6%	11.6%	19.1%
11/3/2023	27.1%	13.7%	46.3%
8/4/2023	1.3%	7.6%	-6.8%
2/28/2023	-21.8%	-20.9%	-33.7%
10/12/2022	-35.0%	-28.2%	-20.3%
8/3/2022	-11.5%	-9.2%	-19.5%
2/23/2022	6.7%	18.4%	17.8%
11/3/2021	22.3%	15.9%	8.9%
8/3/2021	-8.8%	-17.4%	-20.5%
5/5/2021	-8.0%	-3.9%	21.4%
2/24/2021	29.2%	29.8%	36.0%
11/2/2020	-2.3%	-13.7%	-3.5%
8/4/2020	-14.3%	-10.8%	4.2%
3/4/2020	-10.5%	-27.6%	19.2%
11/6/2019	1.6%	4.0%	9.6%
SUMMARY STATS
# Positive	8	8	12
# Negative	13	13	9
Median Positive	7.2%	12.7%	13.7%
Median Negative	-11.5%	-17.4%	-20.5%
Max Positive	29.2%	29.8%	46.3%
Max Negative	-35.2%	-39.3%	-33.7%

SEC Filings

Expand for More

Report Date	Filing
6302025	10-Q 6/30/2025
3312025	10-Q 3/31/2025
12312024	10-K 12/31/2024
9302024	10-Q 9/30/2024
6302024	10-Q 6/30/2024
3312024	10-Q 3/31/2024
12312023	10-K 12/31/2023
9302023	10-Q 9/30/2023
6302023	10-Q 6/30/2023
3312023	10-Q 3/31/2023
12312022	10-K 12/31/2022
9302022	10-Q 9/30/2022
6302022	10-Q 6/30/2022
3312022	10-Q 3/31/2022
12312021	10-K 12/31/2021
9302021	10-Q 9/30/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Coliseum Capital Management, LLC		8142025	Buy	5.15	720,000	3,708,000	63,257,218	Form
1	Coliseum Capital Management, LLC		4102025	Buy	7.96	105,000	835,800	89,613,322	Form
2	Coliseum Capital Management, LLC		4072025	Buy	8.53	160,000	1,364,800	91,992,629	Form
3	Coliseum Capital Management, LLC		3042025	Buy	9.39	1,738,511	16,324,618	88,920,464	Form
4	Leon Jonathan A	EVP, Chief Financial Officer	11252024	Sell	11.82	5,282	62,433	1,546,316	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Owens & Minor (OMI)

Market Price (9/15/2025): $5.24 | Market Cap: $403.1 MilSector: Health Care | Industry: Health Care Distributors

Owens & Minor (OMI)

Market Price (9/15/2025): $5.24Market Cap: $403.1 MilSector: Health CareIndustry: Health Care Distributors

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Owens & Minor (OMI)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Owens & Minor

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/15/2025): $5.24 | Market Cap: $403.1 Mil
Sector: Health Care | Industry: Health Care Distributors

Market Price (9/15/2025): $5.24
Market Cap: $403.1 Mil
Sector: Health Care
Industry: Health Care Distributors